Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease
MRL Pharmaceutical Services, Franklin, TN 37064, USA. Ceftiofur, an extended-spectrum cephalosporin, is active against a variety of animal pathogens, including organisms associated with swine respiratory disease. However, minimum inhibitory concentration (MIC) breakpoint and disk diffusion interpret...
Gespeichert in:
Veröffentlicht in: | Journal of veterinary diagnostic investigation 1996-10, Vol.8 (4), p.464-468 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 468 |
---|---|
container_issue | 4 |
container_start_page | 464 |
container_title | Journal of veterinary diagnostic investigation |
container_volume | 8 |
creator | Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.) Thornsberry, C Yee, Y.C Watts, J.L Yancey, R.J. Jr |
description | MRL Pharmaceutical Services, Franklin, TN 37064, USA.
Ceftiofur, an extended-spectrum cephalosporin, is active against a variety of animal pathogens, including organisms associated with swine respiratory disease. However, minimum inhibitory concentration (MIC) breakpoint and disk diffusion interpretive criteria have not been established for swine pathogens. Susceptibility tests were performed by broth microdilution MIC and disk diffusion methods on 246 bacterial species that cause swine respiratory disease. Ceftiofur was active against Salmonella sp., Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus suis, and Escherichia coli but was not active against Bordetella bronchiseptica measured by MIC. Based on pharmacokinetic studies of ceftiofur in swine after a single intramuscular injection of 3 or 5 mg/kg body weight of ceftiofur and on the MIC and disk diffusion data, we recommend MIC breakpoints and disk diffusion distances, respectively, of |
doi_str_mv | 10.1177/104063879600800411 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78604436</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_104063879600800411</sage_id><sourcerecordid>78604436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-ec2cfb5d12703fd0ad971ed5384b2cd6d55909112ac6d1fd7f7257b5675bdcc13</originalsourceid><addsrcrecordid>eNp9kM1q3TAQhU1pSdO0LxAoaNPu3EjWn70sIU0CgS7arIWsH9-52JYrybncF8hzV8GXbgpZzQzznQPnVNUlwd8IkfKKYIYFbWUnMG4xZoS8qc5Jx2jNOirelr0A9QvxvvqQ0h5j3nBJzqqztuOUU3pePd_P2cUlugxPDpkI5QKNfIhIzxkmMDH0oEeU1mTckqGHEfIRZZcyzAMKHhnnMwS_FsWgYU4Z9dpsNjqlYEBnZ9EB8g6lA8wORZcWiDqHeEQWktPJfazeeT0m9-k0L6rHHze_r-_qh5-399ffH2rDKMm1M43xPbekkZh6i7XtJHGW05b1jbHCct7hjpBGG2GJt9LLErjnQvLeGkPoRfV1811i-LOWDGqCkmsc9ezCmpRsBWaMigI2G1jypxSdV0uEScejIli9lK_-L7-IPp_c135y9p_k1Hb5X23_pAen9mGNcwn7uuOXTbGDYXeA6FSa9DgW_0btnyy0iikmWOEuN87roPQQIanHX6UbLCShfwHIy6ZO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78604436</pqid></control><display><type>article</type><title>Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.) ; Thornsberry, C ; Yee, Y.C ; Watts, J.L ; Yancey, R.J. Jr</creator><creatorcontrib>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.) ; Thornsberry, C ; Yee, Y.C ; Watts, J.L ; Yancey, R.J. Jr</creatorcontrib><description>MRL Pharmaceutical Services, Franklin, TN 37064, USA.
Ceftiofur, an extended-spectrum cephalosporin, is active against a variety of animal pathogens, including organisms associated with swine respiratory disease. However, minimum inhibitory concentration (MIC) breakpoint and disk diffusion interpretive criteria have not been established for swine pathogens. Susceptibility tests were performed by broth microdilution MIC and disk diffusion methods on 246 bacterial species that cause swine respiratory disease. Ceftiofur was active against Salmonella sp., Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus suis, and Escherichia coli but was not active against Bordetella bronchiseptica measured by MIC. Based on pharmacokinetic studies of ceftiofur in swine after a single intramuscular injection of 3 or 5 mg/kg body weight of ceftiofur and on the MIC and disk diffusion data, we recommend MIC breakpoints and disk diffusion distances, respectively, of</description><identifier>ISSN: 1040-6387</identifier><identifier>EISSN: 1943-4936</identifier><identifier>DOI: 10.1177/104063879600800411</identifier><identifier>PMID: 8953533</identifier><language>eng</language><publisher>Los Angeles, CA: J Vet Diagn Invest</publisher><subject>ACTINOBACILLUS PLEUROPNEUMONIAE ; Actinobacillus pleuropneumoniae - drug effects ; Animals ; BORDETELLA BRONCHISEPTICA ; Bordetella bronchiseptica - drug effects ; Cattle ; Cattle Diseases ; CEFALOSPORINAS ; CEPHALOSPORINE ; CEPHALOSPORINS ; Cephalosporins - administration & dosage ; Cephalosporins - pharmacokinetics ; Cephalosporins - pharmacology ; CERDO ; ENFERMEDADES RESPIRATORIAS ; ESCHERICHIA COLI ; Escherichia coli - drug effects ; Injections, Intramuscular ; MALADIE RESPIRATOIRE ; Microbial Sensitivity Tests ; PASTEURELLA MULTOCIDA ; Pasteurella multocida - drug effects ; PORCIN ; RESPIRATORY DISEASES ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - microbiology ; Respiratory Tract Infections - veterinary ; SALMONELLA ; Salmonella - drug effects ; STREPTOCOCCUS SUIS ; Streptococcus suis - drug effects ; SWINE ; Swine Diseases</subject><ispartof>Journal of veterinary diagnostic investigation, 1996-10, Vol.8 (4), p.464-468</ispartof><rights>1996 American Association of Veterinary Laboratory Diagnosticians</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-ec2cfb5d12703fd0ad971ed5384b2cd6d55909112ac6d1fd7f7257b5675bdcc13</citedby><cites>FETCH-LOGICAL-c431t-ec2cfb5d12703fd0ad971ed5384b2cd6d55909112ac6d1fd7f7257b5675bdcc13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8953533$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.)</creatorcontrib><creatorcontrib>Thornsberry, C</creatorcontrib><creatorcontrib>Yee, Y.C</creatorcontrib><creatorcontrib>Watts, J.L</creatorcontrib><creatorcontrib>Yancey, R.J. Jr</creatorcontrib><title>Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease</title><title>Journal of veterinary diagnostic investigation</title><addtitle>J Vet Diagn Invest</addtitle><description>MRL Pharmaceutical Services, Franklin, TN 37064, USA.
Ceftiofur, an extended-spectrum cephalosporin, is active against a variety of animal pathogens, including organisms associated with swine respiratory disease. However, minimum inhibitory concentration (MIC) breakpoint and disk diffusion interpretive criteria have not been established for swine pathogens. Susceptibility tests were performed by broth microdilution MIC and disk diffusion methods on 246 bacterial species that cause swine respiratory disease. Ceftiofur was active against Salmonella sp., Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus suis, and Escherichia coli but was not active against Bordetella bronchiseptica measured by MIC. Based on pharmacokinetic studies of ceftiofur in swine after a single intramuscular injection of 3 or 5 mg/kg body weight of ceftiofur and on the MIC and disk diffusion data, we recommend MIC breakpoints and disk diffusion distances, respectively, of</description><subject>ACTINOBACILLUS PLEUROPNEUMONIAE</subject><subject>Actinobacillus pleuropneumoniae - drug effects</subject><subject>Animals</subject><subject>BORDETELLA BRONCHISEPTICA</subject><subject>Bordetella bronchiseptica - drug effects</subject><subject>Cattle</subject><subject>Cattle Diseases</subject><subject>CEFALOSPORINAS</subject><subject>CEPHALOSPORINE</subject><subject>CEPHALOSPORINS</subject><subject>Cephalosporins - administration & dosage</subject><subject>Cephalosporins - pharmacokinetics</subject><subject>Cephalosporins - pharmacology</subject><subject>CERDO</subject><subject>ENFERMEDADES RESPIRATORIAS</subject><subject>ESCHERICHIA COLI</subject><subject>Escherichia coli - drug effects</subject><subject>Injections, Intramuscular</subject><subject>MALADIE RESPIRATOIRE</subject><subject>Microbial Sensitivity Tests</subject><subject>PASTEURELLA MULTOCIDA</subject><subject>Pasteurella multocida - drug effects</subject><subject>PORCIN</subject><subject>RESPIRATORY DISEASES</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Respiratory Tract Infections - veterinary</subject><subject>SALMONELLA</subject><subject>Salmonella - drug effects</subject><subject>STREPTOCOCCUS SUIS</subject><subject>Streptococcus suis - drug effects</subject><subject>SWINE</subject><subject>Swine Diseases</subject><issn>1040-6387</issn><issn>1943-4936</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1q3TAQhU1pSdO0LxAoaNPu3EjWn70sIU0CgS7arIWsH9-52JYrybncF8hzV8GXbgpZzQzznQPnVNUlwd8IkfKKYIYFbWUnMG4xZoS8qc5Jx2jNOirelr0A9QvxvvqQ0h5j3nBJzqqztuOUU3pePd_P2cUlugxPDpkI5QKNfIhIzxkmMDH0oEeU1mTckqGHEfIRZZcyzAMKHhnnMwS_FsWgYU4Z9dpsNjqlYEBnZ9EB8g6lA8wORZcWiDqHeEQWktPJfazeeT0m9-k0L6rHHze_r-_qh5-399ffH2rDKMm1M43xPbekkZh6i7XtJHGW05b1jbHCct7hjpBGG2GJt9LLErjnQvLeGkPoRfV1811i-LOWDGqCkmsc9ezCmpRsBWaMigI2G1jypxSdV0uEScejIli9lK_-L7-IPp_c135y9p_k1Hb5X23_pAen9mGNcwn7uuOXTbGDYXeA6FSa9DgW_0btnyy0iikmWOEuN87roPQQIanHX6UbLCShfwHIy6ZO</recordid><startdate>19961001</startdate><enddate>19961001</enddate><creator>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.)</creator><creator>Thornsberry, C</creator><creator>Yee, Y.C</creator><creator>Watts, J.L</creator><creator>Yancey, R.J. Jr</creator><general>J Vet Diagn Invest</general><general>SAGE Publications</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19961001</creationdate><title>Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease</title><author>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.) ; Thornsberry, C ; Yee, Y.C ; Watts, J.L ; Yancey, R.J. Jr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-ec2cfb5d12703fd0ad971ed5384b2cd6d55909112ac6d1fd7f7257b5675bdcc13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>ACTINOBACILLUS PLEUROPNEUMONIAE</topic><topic>Actinobacillus pleuropneumoniae - drug effects</topic><topic>Animals</topic><topic>BORDETELLA BRONCHISEPTICA</topic><topic>Bordetella bronchiseptica - drug effects</topic><topic>Cattle</topic><topic>Cattle Diseases</topic><topic>CEFALOSPORINAS</topic><topic>CEPHALOSPORINE</topic><topic>CEPHALOSPORINS</topic><topic>Cephalosporins - administration & dosage</topic><topic>Cephalosporins - pharmacokinetics</topic><topic>Cephalosporins - pharmacology</topic><topic>CERDO</topic><topic>ENFERMEDADES RESPIRATORIAS</topic><topic>ESCHERICHIA COLI</topic><topic>Escherichia coli - drug effects</topic><topic>Injections, Intramuscular</topic><topic>MALADIE RESPIRATOIRE</topic><topic>Microbial Sensitivity Tests</topic><topic>PASTEURELLA MULTOCIDA</topic><topic>Pasteurella multocida - drug effects</topic><topic>PORCIN</topic><topic>RESPIRATORY DISEASES</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Respiratory Tract Infections - veterinary</topic><topic>SALMONELLA</topic><topic>Salmonella - drug effects</topic><topic>STREPTOCOCCUS SUIS</topic><topic>Streptococcus suis - drug effects</topic><topic>SWINE</topic><topic>Swine Diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.)</creatorcontrib><creatorcontrib>Thornsberry, C</creatorcontrib><creatorcontrib>Yee, Y.C</creatorcontrib><creatorcontrib>Watts, J.L</creatorcontrib><creatorcontrib>Yancey, R.J. Jr</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of veterinary diagnostic investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burton, P.J. (MRL Pharmaceutical Services, Franklin, TN.)</au><au>Thornsberry, C</au><au>Yee, Y.C</au><au>Watts, J.L</au><au>Yancey, R.J. Jr</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease</atitle><jtitle>Journal of veterinary diagnostic investigation</jtitle><addtitle>J Vet Diagn Invest</addtitle><date>1996-10-01</date><risdate>1996</risdate><volume>8</volume><issue>4</issue><spage>464</spage><epage>468</epage><pages>464-468</pages><issn>1040-6387</issn><eissn>1943-4936</eissn><abstract>MRL Pharmaceutical Services, Franklin, TN 37064, USA.
Ceftiofur, an extended-spectrum cephalosporin, is active against a variety of animal pathogens, including organisms associated with swine respiratory disease. However, minimum inhibitory concentration (MIC) breakpoint and disk diffusion interpretive criteria have not been established for swine pathogens. Susceptibility tests were performed by broth microdilution MIC and disk diffusion methods on 246 bacterial species that cause swine respiratory disease. Ceftiofur was active against Salmonella sp., Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus suis, and Escherichia coli but was not active against Bordetella bronchiseptica measured by MIC. Based on pharmacokinetic studies of ceftiofur in swine after a single intramuscular injection of 3 or 5 mg/kg body weight of ceftiofur and on the MIC and disk diffusion data, we recommend MIC breakpoints and disk diffusion distances, respectively, of</abstract><cop>Los Angeles, CA</cop><pub>J Vet Diagn Invest</pub><pmid>8953533</pmid><doi>10.1177/104063879600800411</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1040-6387 |
ispartof | Journal of veterinary diagnostic investigation, 1996-10, Vol.8 (4), p.464-468 |
issn | 1040-6387 1943-4936 |
language | eng |
recordid | cdi_proquest_miscellaneous_78604436 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | ACTINOBACILLUS PLEUROPNEUMONIAE Actinobacillus pleuropneumoniae - drug effects Animals BORDETELLA BRONCHISEPTICA Bordetella bronchiseptica - drug effects Cattle Cattle Diseases CEFALOSPORINAS CEPHALOSPORINE CEPHALOSPORINS Cephalosporins - administration & dosage Cephalosporins - pharmacokinetics Cephalosporins - pharmacology CERDO ENFERMEDADES RESPIRATORIAS ESCHERICHIA COLI Escherichia coli - drug effects Injections, Intramuscular MALADIE RESPIRATOIRE Microbial Sensitivity Tests PASTEURELLA MULTOCIDA Pasteurella multocida - drug effects PORCIN RESPIRATORY DISEASES Respiratory Tract Infections - drug therapy Respiratory Tract Infections - microbiology Respiratory Tract Infections - veterinary SALMONELLA Salmonella - drug effects STREPTOCOCCUS SUIS Streptococcus suis - drug effects SWINE Swine Diseases |
title | Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A12%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interpretive%20criteria%20for%20antimicrobial%20susceptibility%20testing%20of%20ceftiofur%20against%20bacteria%20associated%20with%20swine%20respiratory%20disease&rft.jtitle=Journal%20of%20veterinary%20diagnostic%20investigation&rft.au=Burton,%20P.J.%20(MRL%20Pharmaceutical%20Services,%20Franklin,%20TN.)&rft.date=1996-10-01&rft.volume=8&rft.issue=4&rft.spage=464&rft.epage=468&rft.pages=464-468&rft.issn=1040-6387&rft.eissn=1943-4936&rft_id=info:doi/10.1177/104063879600800411&rft_dat=%3Cproquest_cross%3E78604436%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78604436&rft_id=info:pmid/8953533&rft_sage_id=10.1177_104063879600800411&rfr_iscdi=true |